Skip to content

    Cosmo First

    COSMOFIRST
    Capital Goods·12 Nov 2025
    Management Summary

    Cosmo First reported a strong Q2 FY26 with consolidated sales up 21% YoY to Rs. 919 crores and EBITDA up 19% to Rs. 128 crores, driven by higher sales volume and specialty margins. However, commodity film margins faced pressure from imports and US tariffs, and PAT was muted by new capacity-related depreciation and interest. The company is focused on ramping up new lines, expanding specialty products, and improving profitability in its consumer and rigid packaging verticals, while managing debt.

    Highlights

    6
    • Consolidated sales for September'25 quarter is Rs. 919 crores, which is higher compared to Sept 24 quarter by 21%.

    • EBITDA for the quarter has increased by 19% to Rs. 128 crores compared to Rs. 107 crores in September 24 quarter.

    • Higher sales volume by 25%, largely because of the new capacity, contributed Rs. 33 crores to EBITDA.

    • Higher specialty margin contributed Rs. 10 crores and improved performance of Specialty Chemical Subsidiary contributed Rs. 4 crores to EBITDA.

    • Specialty Chemical Subsidiary posted record EBITDA of Rs. 13 crores on top line of Rs. 49 crores in September'25 quarter.

    • Zigly acquired two established veterinary hospitals in Mumbai and Bangalore, both of which are profitability centers.

    Concerns

    5
    • Margin decline on BOPP and BOPET commodity films due to imports in India in Sept 25 quarter, impacting BOPP by Rs. 16 crores and BOPET by Rs. 7 crores.

    • Higher USA tariff (55% post-August) had an adverse impact of Rs. 6 crores in Q2, with an annualized impact of Rs. 55 crores.

    • Stabilization cost related to commissioning of the new line, involving 'a couple of crores' in trials and shutdowns.

    • PAT impact was muted despite EBITDA increase due to increased depreciation and interest related to new capacity.

    • Zigly business is currently making a loss of around Rs. 11.5 crore rupees per quarter, with profitability expected in 3-4 years.

    What Changed1

    vs Q3 FY26

    Guidance items10 → 14 (+4)

    Key financials

    Single quarter

    06 metrics
    1. 01Consolidated Sales₹919 Cr+21%YoY
    2. 02EBITDA₹128 Cr+19%YoY
    3. 03BOPP Gross Margin22 Rs/kg-12%QoQ
    4. 04BOPET Gross Margin6 Rs/kg-50%QoQ
    5. 05Specialty Chemical Subsidiary EBITDA₹13 Cr

    Segment breakdown

    Specialty Chemical Subsidiary
    ₹49 Cr Revenue₹13 Cr EBITDA
    Cosmo Consumers (Window/Paint Protection Film)
    ₹4.5 Cr Sales
    Zigly (Pet Care)
    ₹11.5 Cr Losses
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹250 crores

    Debt

    Net ₹1,230 crores · 3.0x EBITDA

    M&A

    Two established veterinary hospitals

    acquisition · closed

    Guidance & targets

    14
    CategoryTargetPriority
    Revenue
    Overall Revenue
    ₹3500-3800 crores
    Medium
    Revenue
    Specialty Portfolio Revenue
    ₹2200-2500 crores
    Medium
    Revenue
    Paint Protection Film / Sun Control Film Revenue
    ₹20 crores
    High
    Revenue
    Paint Protection Film / Sun Control Film Revenue (Next Year)
    ₹40-60 crores
    High
    Capacity Utilization
    New BOPP Line Utilization
    Fully utilized
    High
    Capacity Utilization
    Rigid Packaging (Cosmo Plastech) Capacity Utilization
    Further increase
    High
    Cost
    Cost Rationalization Impact (Film Business)
    ₹25 crore annualized impact
    High
    Growth
    Specialty Chemical Subsidiary Growth
    Continue growth trend
    High
    Power Consumption
    Renewable Power Consumption Share
    Close to 2/3rd
    High
    Profitability
    Zigly Profitability
    Profitable
    Low
    Debt
    Net Debt Level
    Reduction
    High
    Margin
    BOPP Gross Margin
    Pick up
    Medium
    Corporate Action
    Demerger of Pet Care Vertical
    Demerge
    High
    Product Mix
    Specialty/Semi-specialty volume percentage on new BOPP line
    Close to 70%
    High

    BOPP New Line Utilization

    By Q4 of FY'26
    CurrentClose to 2/3rd of potential in Q2
    TargetFully utilized

    Why it matters

    Full utilization will drive higher sales volume and improve cost efficiency, contributing significantly to overall performance.

    The new BOPP line is ramping up each stage by stage and could achieve close to 2/3rd of potential in Q2. We expect this line to be fully utilized by Q4 of FY'26.

    How to verify

    guidance_and_targets[metric='New BOPP Line Utilization']

    Risks & concerns

    4
    RiskSeverity

    Margin decline on BOPP and BOPET commodity films

    BOPP gross margin dropped to Rs. 22/kg from Rs. 25/kg; BOPET to Rs. 6/kg from Rs. 12/kg due to imports.Management acknowledged

    high

    Higher USA tariff (55%) on film imports

    Annualized impact of Rs. 55 crores, with a net impact of 25% tariff after partial price increases.Management acknowledged

    high

    Stabilization costs for new production lines

    Couple of crores spent on trials and shutdowns during the ramp-up of new lines, muting PAT.Management acknowledged

    medium

    Long gestation period for Zigly business profitability

    Profitability for the pet care vertical may take three to four years from now, currently incurring Rs. 11.5 crore losses per quarter.Management acknowledged

    medium

    Q&A highlights

    8

    “Sure. Earlier it used to be 5%. Post-August, it moved to 55%. So as of now, it is 55% tariff on import of film in USA from India... close to Rs. 6 crore was the impact for the Q2. So, if we annualize, we expect close to Rs. 55 crore annualized impact... we could also take price increases from the customers... remaining net impact for us is close to 25% tariff.”

    Clarifies the significant financial impact of US tariffs and the company's strategy to mitigate it, including the portion passed on to customers.

    asked by Nirav Jimudia

    3 min read6 chapters

    Detailed Narrative

    01

    Q2 FY26 Performance Overview

    Cosmo First reported consolidated sales of Rs. 919 crores for Q2 FY26, marking a 21% increase compared to the September 2024 quarter. EBITDA grew by 19% to Rs. 128 crores, up from Rs. 107 crores in the prior year. This growth was primarily driven by a 25% higher sales volume, largely attributable to new capacity. However, the company noted that PAT growth was muted due to increased depreciation and interest expenses associated with these new investments.

    02

    Margin Pressures and Mitigation Strategies

    Gross margins for BOPP and BOPET films experienced significant pressure in Q2 FY26. BOPP gross margin declined to Rs. 22 per kg from Rs. 25 per kg in the previous quarter, while BOPET dropped to Rs. 6 per kg from Rs. 12 per kg. This was mainly due to increased imports in India and a 55% US tariff, which had an adverse impact of Rs. 6 crores in Q2, with an annualized impact of Rs. 55 crores. The company has partially passed on these tariffs through price increases and expects margins to improve as imports curtail and demand-supply dynamics stabilize.

    03

    Focus on Specialty Products and Cost Efficiency

    The company is strategically focusing on expanding its specialty film portfolio and aims to achieve an annualized cost rationalization impact of Rs. 25 crores within the next 12-15 months. The Specialty Chemical Subsidiary demonstrated strong performance, posting a record EBITDA of Rs. 13 crores on Rs. 49 crores in revenue for the quarter. Management plans to increase the specialty/semi-specialty product mix on its new BOPP line from the current 18-20% in Q2 to approximately 70% over the next 12 months.

    04

    New Business Verticals Update

    Cosmo Plastech, the Rigid Packaging business, reached close to 70% capacity utilization in Q2, with expectations for further increases in coming quarters. Consumer businesses, including Zigly (pet care) and Cosmo Consumers (window film, paint protection film, ceramic coating), are scaling up. Zigly acquired two profitable veterinary hospitals in Mumbai and Bangalore. While the Cosmo Consumers segment is projected to achieve Rs. 20 crores in revenue this fiscal year, Zigly's profitability is anticipated to take three to four years from now, despite scaling revenue without increasing losses.

    05

    Capital Structure and Future Capex Plans

    As of September 2025, the company's net debt stood at Rs. 1230 crores, resulting in a net debt to EBITDA ratio of 2.97x. Cosmo First has planned Rs. 250 crores in capex for FY26, which includes two new lines expected to be commissioned by Q1 FY27. Beyond this, management indicated a consolidation phase with no major capex planned for the next 18 months, expressing confidence that net debt reduction will occur in the coming years due to controlled capital expenditure.

    06

    Renewable Energy and Market Diversification

    The company is committed to increasing its renewable power consumption, targeting close to two-thirds of its power from renewable sources within 12-15 months, which will also facilitate cost rationalization. In response to US tariffs, Cosmo First will evaluate further price increases after December if duties persist, while actively expanding its export footprint to other regions such as the Americas, Europe, Middle East, and Africa, covering approximately 70% of the world market.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.